SRx Health Solutions Inc. (SRXH)
Official siteCONSUMER DEFENSIVE • MEDICAL CARE FACILITIES • AMEX
Market Cap: $19.21M
Last updated: Nov 17, 2026 at 11:04 AM ET
SRx Health Solutions Inc. (SRXH) Financials: Revenue, Profit and Cash Flow
SRx Health Solutions reported revenue of $6.53M for the fiscal year ended Sep 30, 2025, down 87.0% from the year before. That year, net income was -$45.01M with a net margin of -688.8%, operating cash flow was -$8.14M and free cash flow was -$10.22M. The quarter ended Jun 30, 2026 had revenue of $3.39M and net income of -$4.14M.
Revenue and Margins
Over the 8 years to Sep 2025, revenue grew from $2.16K, a compound annual rate of 172.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $6.53M | -87.0% | 23.4% | -174.6% | -688.8% |
| Sep 2024 | $50.30M | -68.9% | 36.8% | -17.1% | -0.5% |
| Sep 2023 | $161.55M | +74.4% | 19.9% | -4.9% | -9.4% |
| Sep 2022 | $92.63M | +58.0% | 14.4% | -1.3% | -2.6% |
| Sep 2021 | $58.63M | +7.8% | 29.8% | -37.6% | 6.5% |
| Sep 2020 | $54.38M | N/A | 33.7% | -64.2% | -139.3% |
| Sep 2018 | N/A | N/A | N/A | N/A | N/A |
| Sep 2017 | $2.16K | N/A | 80.7% | -30226.1% | -100549.7% |
| Sep 2016 | N/A | N/A | N/A | N/A | N/A |
| Sep 2015 | N/A | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Sep 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.53M | $50.30M | $161.55M | $92.63M | $58.63M | $54.38M | N/A | $2.16K | N/A | N/A |
| Cost of revenue | $5.01M | $31.80M | $129.48M | $79.33M | $41.17M | $36.06M | N/A | N/A | $2.86K | $2.90K |
| Gross profit | $1.53M | $18.49M | $32.07M | $13.31M | $17.47M | $18.32M | N/A | $1.75K | -$2.80K | -$2.90K |
| Research and development | $0 | $143.81K | $132.55K | $671.82K | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$11.41M | -$8.58M | -$7.89M | -$1.17M | -$22.02M | -$34.89M | -$685.70K | -$654.09K | -$275.03K | -$32.60K |
| Net income | -$45.01M | -$241.60K | -$15.13M | -$2.45M | $3.80M | -$75.76M | -$14.27M | -$2.18M | -$1.22M | -$65.69K |
| EBITDA | -$7.98M | $6.40M | N/A | $1.01M | $10.58M | N/A | -$685.70K | -$654.09K | N/A | -$29.71K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.39M | $3.44M | $2.81M | -$47.05M | $11.45M | $7.16M | $34.98M | $15.36M | $42.67M | $7.90M | $17.76M | $13.96M |
| Gross profit | $904.00K | $1.35M | $1.05M | -$15.46M | $1.62M | $2.38M | $12.99M | $6.06M | $9.42M | $2.61M | $5.44M | $4.20M |
| Operating income | -$3.20M | -$1.82M | -$3.79M | $10.38M | -$14.73M | -$1.09M | -$5.97M | -$1.52M | -$1.32M | -$2.47M | -$3.54M | -$3.42M |
| Net income | -$4.14M | -$6.38M | -$8.61M | -$21.28M | -$15.13M | -$964.00K | -$168.00K | $2.06M | -$3.12M | -$2.83M | -$2.20M | -$3.93M |
Balance Sheet
As of Sep 2025, total debt of $4.47M exceeded cash and equivalents by $3.16M.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $8.40M | $22.72M | $42.05M | $34.79M | $98.67M | $65.44M | $271.58K | $27.08K | $28.73K | N/A |
| Current assets | $8.13M | $21.57M | $25.13M | $14.80M | $55.97M | $22.43M | $271.58K | $20.38K | $21.72K | N/A |
| Cash and equivalents | $1.31M | $4.74M | $2.07M | $1.66M | $36.89M | $5.09M | $259.37K | $1.80K | $13.31K | N/A |
| Total liabilities | $8.00M | $120.62M | $70.80M | $33.86M | $24.91M | $101.33M | $3.71M | $1.50M | $771.29K | N/A |
| Short-term debt | $21.00K | $52.91M | $35.81M | $6.56M | $1.16M | $10.46M | $353.22K | $788.53K | $348.82K | N/A |
| Long-term debt | $4.45M | $696.00K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | $407.00K | $13.91M | $15.08M | $62.20M | $73.76M | -$35.88M | -$3.44M | -$1.47M | N/A | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $145.36M | $43.36M | $27.05M | $11.72M | $33.98M | $10.63M | $22.72M | $23.20M | $17.90M | $20.96M | $42.05M | $40.28M |
| Total liabilities | $2.37M | $25.08M | $23.53M | $11.15M | $79.86M | $5.09M | $10.29M | $9.28M | $12.51M | $19.43M | $21.63M | $18.78M |
| Cash and equivalents | $36.69M | $20.54M | $13.06M | $1.83M | $912.00K | $790.21K | $4.41M | $6.41M | $4.50M | $5.26M | $5.15M | $4.78M |
| Shareholder equity | $142.99M | $18.29M | $3.52M | $567.65K | -$45.88M | $5.53M | $12.44M | $13.91M | $5.39M | $1.53M | $20.42M | $21.49M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Sep 2025.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.14M | N/A | $97.00K | -$20.55M | -$15.11M | N/A | -$1.04M | -$49.62K | N/A |
| Capital expenditures | $2.08M | N/A | $18.00K | $198.00K | $449.89K | $192.81K | $0 | N/A | $235.71K |
| Free cash flow | -$10.22M | N/A | $79.00K | -$20.75M | -$15.56M | N/A | -$1.04M | N/A | N/A |
| Investing cash flow | $5.91M | N/A | -$18.00K | -$198.00K | -$449.89K | -$192.81K | N/A | N/A | -$326.29K |
| Financing cash flow | $12.17M | $7.08M | -$5.10M | $1.28M | $47.36M | $11.74M | $1.30M | $38.69K | $575.31K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$956.00K | -$3.62M | -$2.92M | $7.60M | -$16.13M | $384.00K | -$1.68M | -$2.98M | $27.35K | -$1.01M | $464.50K | $312.64K |
| Capital expenditures | $0 | $0 | $8.46M | $0 | $7.00K | $7.00K | $17.26K | $14.86K | $20.51K | $3.00K | $0 | $0 |
| Free cash flow | -$956.00K | -$3.62M | -$11.38M | $7.60M | -$16.14M | $377.00K | -$1.70M | -$2.99M | $6.84K | -$1.01M | $464.50K | $312.64K |
Frequently Asked Questions About SRXH
What is SRx Health Solutions' annual revenue?
SRx Health Solutions reported revenue of $6.53M for the fiscal year ended Sep 30, 2025.
How fast is SRx Health Solutions' revenue growing?
Revenue was down 87.0% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -58.7%.
Is SRx Health Solutions profitable?
No. SRx Health Solutions reported net income of -$45.01M for the fiscal year ended Sep 30, 2025, with a net margin of -688.8%.
How much free cash flow does SRXH generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of -$8.14M minus capital expenditures of $2.08M produced free cash flow of -$10.22M.
How much debt does SRx Health Solutions have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $4.45M, short-term debt of $21.00K and cash and equivalents of $1.31M.
SRXH pages: Overview, Earnings, Financials